The multicenter, double-crossover, cluster-randomized clinical trial involved four LTCFs in metropolitan and regional South Australia. Eight zones covering a total of 211,952 bed-days were assessed over 110 weeks between August 2021 and November 2023. Each facility was divided into two zones, which alternated between active GUV appliances and inactive controls in six-week intervention periods separated by washout phases.
The following were the key findings of the study:
- A total of 596 acute respiratory infections (ARIs) were recorded during the study.
- Of these, 79.7% occurred during the intervention or control periods.
- The control group had an incidence rate of 4.17 infections per zone per cycle.
- The GUV intervention group recorded 3.81 infections per zone per cycle.
- The incidence rate ratio was 0.91, which was not statistically significant.
- A secondary time-series analysis showed a mean reduction of 0.32 infections per week in the GUV group.
- This reduction translated to a 12.2% overall decrease in ARIs throughout the study.
The findings suggest that while GUV did not significantly impact infection rates within individual study cycles, it contributed to a modest but meaningful decline in total ARI cases over time. According to the authors, this supports the potential role of GUV as an adjunct to existing infection control measures, particularly in settings with vulnerable elderly populations.
The study did have several limitations. The COVID-19 pandemic and associated public health restrictions affected study design, data collection, and diagnostic testing capabilities. Limited access to facilities prevented environmental sampling, and movement between intervention and control zones may have influenced outcomes. Additionally, many ARI cases were not confirmed through laboratory testing due to constrained diagnostic resources, and the results are specific to commercially available GUV devices used in the trial.
Despite these constraints, the research highlights the potential of GUV-based strategies to help mitigate airborne respiratory infections in long-term care environments. If proven cost-effective, integrating GUV with conventional infection control protocols could strengthen preparedness against seasonal outbreaks and emerging viral threats.
The authors emphasize the need for further research to optimize GUV deployment patterns and assess their impact across various facility layouts and infection prevalence levels.
Reference:
Shoubridge AP, Brass A, Crotty M, et al. Germicidal UV Light and Incidence of Acute Respiratory Infection in Long-Term Care for Older Adults: A Randomized Clinical Trial. JAMA Intern Med. Published online July 28, 2025. doi:10.1001/jamainternmed.2025.3388
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.